Evidence map›Paper›PMID 36695860›Full record

ArticleInternational urogynecology journal2023

Establishment and initial implementation of the Australasian Pelvic Floor Procedure Registry.

Randi T Jayasinghe, Rasa Ruseckaite, Joanne Dean, Aruna Kartik, Anagi C Wickremasinghe, Oliver Daly, Helen E O'Connell, Amanda Craig, Anne Duggan, Dora Vasiliadis and 12 more

Abstract read
In one paragraph

Article in International urogynecology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Randi T JayasingheDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia. randi.jayasinghe@monash.edu.ORCID 0000-0003-2577-2528
Rasa RuseckaiteDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
Joanne DeanDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
Aruna KartikDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
Anagi C WickremasingheDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
Oliver DalyDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
Helen E O'ConnellDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
Amanda CraigDepartment of Health and Aged Care, Therapeutic Goods Administration, Canberra, Australia.
Anne DugganAustralian Commission on Safety and Quality in Health Care, Sydney, Australia.
Dora VasiliadisConsumer Representative, Australasian Pelvic Floor Procedure Registry, Melbourne, Australia.
Emmanuel KarantanisSt George Hospital, Kogarah, Australia.
Elizabeth GallagherCalvary John James, Canberra Private and Canberra Hospital, Canberra, Australia.
Gwili HolmeCommonwealth of Australia, Canberra, Australia.
James KeckSt Vincent's Private Hospital Melbourne, Melbourne, Australia.
Jarrod WilliamsMinistry of Health New Zealand, Wellington, New Zealand.
Jennifer KingWestmead Hospital, Westmead, Australia.
Jessica YinHolywood Medical Centre (WA), Nedlands, Australia.
John ShortChristchurch Women's Hospital & Southern Cross Hospital - Invercargill, Christchurch, New Zealand.
Kirstine Sketcher-BakerClinical Excellence Queensland, Queensland Health, Herston, Australia.
Pip BrennanConsumer Representative, Australasian Pelvic Floor Procedure Registry, Melbourne, Australia.
Sally RaynerCommonwealth of Australia, Canberra, Australia.
Susannah AhernDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisStress urinary incontinence (SUI) and pelvic organ prolapse (POP) are common pelvic floor disorders (PFDs). Owing to significant adverse events associated with mesh-related pelvic floor procedures (PFPs) in a proportion of the surgically treated population, and deficits in collection and reporting of these events, the Australian Government identified an urgent need for a tracking mechanism to improve safety and quality of care. The Australasian Pelvic Floor Procedure Registry (APFPR) was recently established following the 2018 Senate Committee Inquiry with the aim of tracking outcomes of PFP involving the use of devices and/or prostheses, with the objective of improving the health outcomes of women who undergo these procedures. This paper will describe the APFPR's aims, development, implementation and possible challenges on the way to its establishment.

methodsThe APFPR has been developed and implemented in accordance with the national operating principles of clinical quality registries (CQRs). The minimum datasets (MDS) for the registry's database have been developed using a modified Delphi process, and data are primarily being collected from participating surgeons. Patient recruitment is based on an opt-out approach or a waiver of consent. Patient-reported outcome measures (PROMs) providing additional health and outcome information will be obtained from participating women to support safety monitoring of mesh-related adverse events.

resultsCurrently in the Australasian Pelvic Floor Procedure Registry (APFPR) there are 32 sites from various jurisdictions across Australia, that have obtained relevant ethics and governance approvals to start patient recruitment and data collection as of January 2023. Additionally, there are two sites that are awaiting governance review and five sites that are having documentation compiled for submission. Seventeen sites have commenced patient registration and have entered data into the database. Thus far, we have 308 patients registered in the APFPR database. The registry also published its first status report and a consumer-friendly public report in 2022.

conclusionsThe registry will act as a systematic tracking mechanism by collecting outcomes on PFP, especially those involving devices and/or prostheses to improve safety and quality of care.

Indexed as

Pelvic Organ ProlapseUrinary Incontinence, StressAustraliaFemaleHumansPelvic FloorRegistriesAustralasian Pelvic Floor Procedure RegistryClinical Quality RegistryPelvic Floor Procedures, Pelvic Organ Prolapse, Devices and Prostheses, Stress Urinary Incontinence

Identifiers

PMID36695860
PMCPMC10415488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.